Stockreport

UroGen Is A Compelling Value With Recent FDA Approval [Seeking Alpha]

Alphabet Inc. - Class C Capital Stock  (GOOG) 
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
PDF SummaryUGN-101/Jelmyto was recently "fast-tracked" FDA approved as a "breakthrough" orphan therapy for ~7,000 patients/year (6 doses at $21,376/dose) for a ~$900 million [Read more]